THROMBOELASTOGRAPHY MARKET ANALYSIS

Market Challenges And Opportunities

Global Thromboelastography Market– Drivers

Increasing number of product launches by market players is expected to drive the global thromboelastography market growth over the forecast period. For instance, on April 28, 2022, Nordic Biomarker is a Sweden based manufacturer of advance reagent, calibrators and controls for coagulation and clinical chemistry analyzers launched vWF Antigen. “Von Willebrand factor”, which is a large protein that plays an important part in the coagulation process. Up to 1% of people have von Willebrand Disease (vWD), the most prevalent inherited bleeding illness. The diagnosis denotes either a lack of sufficient quantity or quality of vWF, which causes abnormal bleeding in the patient. A vWF Antigen assay is one of the several processes that make up the difficult diagnosing procedure.

The increase in number of research and development activities is expected to boost the growth of global thromboelastography market over the forecast period. For instance, on January 10, 2020, an article published in Multidisciplinary Digital Publishing Institute (MDPI), Viscoelastic tests results does not clearly split platelet count from function. Moreover, extensive thrombin generation from standard activated viscoelasticity assays activates platelets through protease-activated receptors, bypassing other pathways. For this reason, standard viscoelastic tests cannot be used to assess platelet reactivity under the action of aspirin or P2Y12 inhibitors. To overcome this problem a new technique was developed called as thromboelastography platelet mapping, it is a modification of the standard TEG and it evaluates platelet function through direct activation of arachidonic acid (AA) and adenosine diphosphate (ADP) receptors.

Global Thromboelastography Market– Restraints

Standard platelet concentrates (PCs) are to be stored at 22 °C and it has shelf life of 5 days. Due to storage temperatures, bacterial contamination of PCs can lead to life-threatening infections in transfusion patients. For instance, on December 06, 2021, a recent article published in Association for the Advancement of Blood & Biotherapies (AABB), stated that, Thromboelastometry assays have been applied to assess standard platelet concentrates quality globally. A study using thromboelastography on buffy coat standard platelet concentrates revealed that this method may not be sensitive enough to detect quality changes associated with normal storage.